Home >> About LifeSync® Corp. >> Board of Directors
GMP Companies, Inc. Board of Directors.
LifeSync Corporation is a wholly owned subsidiary and the sole commercial business of GMP Companies, Inc. (GMP)
Shelley A. Hartman
Chairman of the Board, President and Chief Executive Officer
Ms. Hartman joined GMP in late 2004 as President and CEO after more than 18 years in the investment banking industry, where she served most recently as Managing Director in the Healthcare Department of the Investment Banking Division at Goldman, Sachs & Co. During her tenure, she was responsible for the firm’s worldwide efforts in the Medical Device Industry and, prior to that, for the firm’s worldwide efforts in the Healthcare Services Industry. Before joining Goldman Sachs, Ms. Hartman served as Vice President in the Healthcare Group at Credit Suisse First Boston. Ms. Hartman received her Bachelor of Arts degree in Economics from Wellesley College in Wellesley, Massachusetts.
Charles L. Brown III, M.D.
Director
Dr. Brown has served as a director since May 1999 and was the President of GMP Companies, Inc. from May 1999 until September 1999. Dr. Brown has been a partner in Cardiology of Georgia, a cardiology practice, since August 1992. Dr. Brown specializes in interventional cardiology and is the Director of the Fuqua Heart Center Research Department at Piedmont Hospital in Atlanta, Georgia. He oversees several clinical trials and is the principal investigator for many of these studies. He is the inventor or co-inventor of nine patents that were assigned to Global Vascular Concepts, the predecessor to two of the company's original subsidiaries.
Paul A. Brooke
Director
Mr. Brooke became a director of GMP Companies, Inc. in June 2006. Mr. Brooke is Chairman and Chief Executive Officer of Ithaka Acquisition Corporation, a publicly-traded special purpose acquisition company, he has also been the Managing Member of PMSV Holdings LLC, a private investment firm, since 1993 and a Venture Partner of MPM Capital, a venture capital firm specializing in the healthcare industry, since 1997. Mr. Brooke has also been an Advisory Director to Morgan Stanley since April 2000. From 1983 until April 1999, Mr. Brooke was a Managing Director and the Global Head of Healthcare Research and Strategy at Morgan Stanley. From April 1999 until May 2000, he was a Managing Director at Tiger Management LLC. He serves as a member of the Boards of Directors of the following public companies: Emdeon, a healthcare information company; Ithaka Acquisition Corporation mentioned above, Incyte Corporation, a drug discovery company; and Viropharma Incorporated, a pharmaceutical company. He also serves as a director of a number of privately-held firms.
Eric Hecht, M.D.
Director
Dr. Hecht is President and Chief Financial Officer of Ithaka Acquisition Corporation, a publicly-traded special purpose acquisition company, as well as Executive Chairman of Houston Pharma, a private biotech company. From 1992 to 1997, Dr. Hecht was the senior biotech analyst at Morgan Stanley, and from 1997-2002 he held the same position at Merrill Lynch. He is a graduate of the Albert Einstein College of Medicine.
B. Kristine Johnson
Director
Ms. Johnson is a General Partner at Affinity Capital, a venture capital firm that invests in private, U.S.-based health care companies. Previously, she was senior vice president and chief administrative officer of Medtronic. During her 17 years at Medtronic, she was also president and general manager of Medtronic’s Vascular business and Medtronic’s Tachyarrhythmia Management business.
Matthew Rebold
Director
Mr. Rebold is Managing Partner of Osprey Partners, a NASD member firm, specializing in global placement of alternative investments, such as hedge funds and private equity partnerships. Prior to that, Mr. Rebold was Director of Marketing for Tiger Management Corporation. Mr. Rebold holds an MBA in Finance from the Wharton School, University of Pennsylvania, and a BA in Public Policy Studies from Duke University.
Alan Sebulsky
Director
Since April 2003, Mr. Sebulsky has served as Managing Partner and Portfolio Manager at Apothecary Capital LLC, an investment advisory firm specializing in health care. Prior to joining Apothecary Capital LLC, he was an independent investor and consultant. Mr. Sebulsky was also previously at Lincoln Capital Management, a private investment management firm, where he was responsible for its health care investments from July 1994 to January 2002, last serving as a Managing Director. From 1988 to May 1994, he was with Morgan Stanley & Company, an international investment banking and brokerage firm, with responsibility for equity research in the pharmaceutical and medical device industries, last serving as a Managing Director. He also previously held various positions at T. Rowe Price & Associates, an investment management firm, from 1982 to 1988, serving as a health care investment analyst and portfolio manager. He is currently serving on the Boards of Directors of Arrow International, a NASDAQ-listed medical device company, and Jazz Pharmaceuticals, a privately-held specialty pharmaceutical company.
